BioSpace News Archive

BioCapital

Integrity Applications Announces Re-Order of GlucoTrack Devices

The recent order of GlucoTrack, in the amount of US$460,000, was a re-order from an existing customer and represents a nearly two-fold increase from the original order.

November 1, 2017
·
4 min read
Business

Juno Therapeutics Reports Third Quarter 2017 Financial Results

Revenue for the three and nine months ended September 30, 2017 was $44.8 million and $85.4 million, compared to $20.8 million and $58.2 million for the three and nine months ended September 30, 2016, respectively.

November 1, 2017
·
23 min read
Business

BIOLASE Reports 2017 Third Quarter and Nine-Month Results

The Company’s strategy of increasing its focus on new customers in the much larger “Early Majority” market segment resulted in new customers representing three-quarters of the all-tissue laser systems sales during the third quarter of 2017.

November 1, 2017
·
18 min read
Business

Quidel Reports Third Quarter 2017 Financial Results

Total revenue for the third quarter of 2017 increased 3% over the third quarter of 2016 to $50.9 million.

November 1, 2017
·
17 min read
Business

AtriCure Reports Third Quarter 2017 Financial Results

Revenue for the third quarter of 2017 was $42.2 million, an increase of $3.8 million or 9.9% (9.3% on a constant currency basis), compared to third quarter 2016 revenue.

November 1, 2017
·
11 min read
Business

Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights

Foundation Medicine reported total revenue of $42.7 million in the third quarter of 2017, compared to $29.4 million in the third quarter of 2016.

November 1, 2017
·
9 min read
Business

Synthetic Biologics Reports Third Quarter 2017 Operational Highlights and Financial Results

Synthetic Biologics today provided an operational update and reported financial results for the three months ended September 30, 2017.

November 1, 2017
·
14 min read